Measurements of electrodynamic effects on the deposition of mdi and dpi aerosols in a replica cast of human oral-pharyngeal-laryngeal airways

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 22, Issue 1, 2009, Pages 35-44

  Ali, Mohammed ^a   Mazumder, Malay K ^b   Martonen, Ted B ^c,d  

^a Jackson State University   (United States)

^b University of Arkansas   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d CyberMedicine Inc   (United States)

Author keywords

Aerodynamic size; Aerosol deposition; DPI; Electrostatic charge; MDI; Replica cast

Indexed keywords

IPRATROPIUM BROMIDE; TIOTROPIUM BROMIDE;

AEROSOL; ARTICLE; CADAVER; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; DRY POWDER INHALER; ELECTRICITY; LARYNX; METERED DOSE INHALER; OROPHARYNX; PARTICLE SIZE;

AEROSOLS; HUMANS; LARYNX; METERED DOSE INHALERS; NEBULIZERS AND VAPORIZERS; OROPHARYNX; PARTICLE SIZE; POWDERS; STATIC ELECTRICITY;

EID: 65349134960     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2007.0637     Document Type: Article

References (30)

1. Patel P, Mukai D, Wilson AF: Dose response effects of two sizes of monodisperse isoproterenol in mild asthma. Am Rev Respir Dis. 1990;141:357-360.
2. Martonen TB, Smyth HD, Isaacs KK, Burton R: Issues in drug delivery: concepts and practice. Respir Care. 2005;50:1228-1252.
3. Katz IM, Davis BM, Martonen TB: A numerical study of particle motion within the human larynx and trachea. J Aerosol Med. 1999;30:173-180.
4. Schroeter JD, Musante CJ, Huang D, Burton R, Guilmette R, Martonen TB: Hygroscopic growth and deposition of inhaled secondary cigarette smoke in human nasal pathways. Aerosol Sci Technol. 2001;34:137-143.
5. Martonen TB, Rosati JA, Isaacs KK: Modeling deposition of inhaled particles. In LS Ruzer, NH Harley (eds). Aerosols Handbook: Measurements, Dosimetry, and Health Effects. CRC Press, Boca Raton, FL, pp. 113-155, 2005.
6. Martonen TB, Yang Y: Deposition mechanics of pharmaceutical particles in human airways. In: AJ Hickey (ed). Inhalation Aerosols. Marcel Dekker, New York, pp. 3-28.
7. Orehek J, Gayrard P, Grimaud CH, Charpin J: Patient error in use of bronchodilator metered aerosols. Br Med J. 1976;1:76.
8. Moren F, Anderson J, Stiksa G: Mode of inhalation for trained and untrained asthmatics using a pressurized aerosol. Respiration. 1984;45:56-60.
9. Kim CS, Eldridge MA, Sackner MA: Oropharyngeal deposition and delivery aspects of metered dose inhaler aerosols. Am Rev Respir Dis. 1987;135:157-164.
10. Fink JB: Metered dose inhalers, dry powder inhalers and transitions. Respir Care. 2000;45:623-635.
11. Newman SP, Clarke AR, Talaee N, Clarke SW: Lung deposition of 5 mg Intal from a pressurized metered dose inhaler assessed by radiotracer technique. Int J Pharm. 1991;74:203-208.
12. Biddiscombe MF, Melchor R, Mark VHF, Marriott RJ, Taylor AJ, Short MD, Spiro SG: The lung deposition of salbutamol, directly labeled with technetium -99m, delivered by pressurized metered dose and dry powder inhalers. Int J Pharm. 1993;91:111-121.
13. Cheng YS: Modeling aerosol drug delivery. In L Gradon, J Marijnissen (eds). Optimization of Aerosol Drug Delivery. Kluwer Academic Publishers, Boston, pp. 165-188, 2003.
14. Swift DL: The oral airway - a conduit or collector for pharmaceutical aerosols. In: PR Byron, RN Dalby, SJ Farr (eds). Respiratory Drug Delivery IV. Interperm Press, Deerfield, IL, pp. 187-195, 1994.
15. Hinds WC: Aerosol Technology: Properties, Behavior and Measurement of Airborne Particles, 2nd ed. John Wiley & Sons, Inc., New York, 1998.
16. Yu CP: Precipitation of unipolarly charged particles in cylindrical and spherical vessels. J Aerosol Sci. 1977;8:237-241.
17. Melandri C, Tarroni G, Prodi V, Zaiacomo TD, Formignani M, Lombardi C: Deposition of charged particles in the human airways. J Aerosol Sci. 1983;14:657-669.
18. Hashish AH, Bailey AG, Williams TJ: Selective deposition of pulsed charged aerosols in the human lung. J Aerosol Med. 1994;7:167-171.
19. Balachandran W, Machowski W, Gaura E, Hudson C: Control of drug aerosol in human airways using electrostatic forces. J Electrostat. 1997;40-41:579-584.
20. Cohen BS, Xiong JQ, Fang CP, Li W: Deposition of charged particles on lung airways. Health Phys. 1998;74:554-560.
21. Staniforth JN: The importance of electrostatic measurements in aerosol formulation and preformulation. In PR Byron, RN Dalby, SJ Farr (eds). Respiratory Drug Delivery IV. Interperm Press, Deerfield, IL, pp. 303-311, 1994.
22. Bailey AG, Hashish AH, Williams TJ: Drug delivery by inhalation of charged particles. J Electrostat. 1998;44:3-10.
23. Orban JC, Peart J: Simultaneous electrostatic charge characterization and particle size analysis of metered dose inhalers (pMDIs) using the electrical low pressure impactor. In RN Dalby, PR Byron, J Peart, JD Suman, SJ Farr (eds). Respiratory Drug Delivery IX. Virginia Commonwealth University, Richmond, VA, pp. 877-880, 2004.
24. Finlay WH: The Mechanics of Inhaled Pharmaceutical Aerosols: An Introduction. Academic Press, San Diego, CA, 2001.
25. Geller DE, Eigen H, Fiel SB, Clark A, Lamare AP, Johnson CA, Konstan MW: Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Pediatr Pul-monol. 1998;25:83-87.
26. Glover W, Chan HK: Electrostatic charge characterization of pharmaceutical aerosols using electrical low-power im-paction (ELPI). J Aerosol Sci. 2004;35:755-764.
27. Mazumder MK, Ware RE: Aerosol particles charge and size analyzer, US Patent # 4633714, 1987.
28. Zhang Y, Finlay WH, Matida EA: Particle deposition measurements and numerical simulation in a highly idealized mouth-throat. J Aerosol Sci. 2004;35:789-803.
29. Zhang Y, Chia TL, Finlay WH: Experimental measurement and numerical study of particle deposition in highly idealized mouth-throat models. Aerosol Sci Technol. 2006;40: 361-372.
30. Cross JA: Electrostatics: Principles, Problems and Applications. Institute of Physics Publishing, Bristol, England, 1987.